Episodes

Dr Melinda Gooderham speaks with JCMS Editor-in-chief Dr Kirk Barber about her literature review in the May/June 2019 edition of JCMS. Dr Gooderham and her co-author Nicole Relke looked at vitiligo pathophysiology, reviewed current therapy and discussed the potential value of JAK inhibitors. Their literature review shows JAK inhibitors in patients with vitiligo have a favorable safety profile and effectively produce repigmentation of lesions, especially with concomitant ultraviolet exposure. Dr...

Dr Mark Kirchhof speaks with JCMS Editor-in-chief Dr. Kirk Barber about his innovative proposal for the treatment of Hidradenitis Suppurativa (HS). Clinicians typically follow a linear approach to the treatment of HS in which one modality is attempted before moving on to the next. Dr Kirchhoff's paper challenges this sequential approach to treating Hidradenitis Suppurativa and instead proposes a model that allows for HS to be measured in a more dynamic fashion and he offers a treatment algorithm...

Dr Mark Kirchhof speaks with JCMS Editor-in-chief Dr. Kirk Barber about his innovative proposal for the treatment of Hidradenitis Suppurativa (HS). Clinicians typically follow a linear approach to the treatment of HS in which one modality is attempted before moving on to the next. Dr Kirchhoff's paper challenges this sequential approach to treating Hidradenitis Suppurativa and instead proposes a model that allows for HS to be measured in a more dynamic fashion and he offers a treatment algorithm...

Dr Mark Kirchhof speaks with JCMS Editor-in-chief Dr. Kirk Barber about his innovative proposal for the treatment of Hidradenitis Suppurativa (HS). Clinicians typically follow a linear approach to the treatment of HS in which one modality is attempted before moving on to the next. Dr Kirchhoff's paper challenges this sequential approach to treating Hidradenitis Suppurativa and instead proposes a model that allows for HS to be measured in a more dynamic fashion and he offers a treatment algorithm...

JCMS editor-in-chief Dr Kirk Barber speaks with Dr Patrick Fleming, one of the authors of a new manuscript that offers an extensive comparison of international guidelines on a wide range of therapies for the treatment of moderate-to-severe plaque psoriasis from phototherapy, to biologics to molecule-based strategies. Dr Fleming and his co-authors looked at the guidelines in Canada, the United Kingdom, Europe and the United States. In this conversation, Dr Fleming highlights some surprising diffe...

JCMS editor-in-chief Dr Kirk Barber speaks with Dr Patrick Fleming, one of the authors of a new manuscript that offers an extensive comparison of international guidelines on a wide range of therapies for the treatment of moderate-to-severe plaque psoriasis from phototherapy, to biologics to molecule-based strategies. Dr Fleming and his co-authors looked at the guidelines in Canada, the United Kingdom, Europe and the United States. In this conversation, Dr Fleming highlights some surprising diffe...

JCMS editor-in-chief Dr Kirk Barber speaks with Dr Patrick Fleming, one of the authors of a new manuscript that offers an extensive comparison of international guidelines on a wide range of therapies for the treatment of moderate-to-severe plaque psoriasis from phototherapy, to biologics to molecule-based strategies. Dr Fleming and his co-authors looked at the guidelines in Canada, the United Kingdom, Europe and the United States. In this conversation, Dr Fleming highlights some surprising diffe...

Despite the lack of evidence to validate the effectiveness and safety of marijuana, it is approved to treat a variety of dermatologic conditions in the United States. Health Canada has listed psoriasis, dermatitis, and pruritus as potential therapeutic uses for cannabis. Furthermore, medical cannabis dispensaries have been making unsubstantiated claims about medical cannabis. It is important for dermatologists to know about the purported uses of medical cannabis to help patients navigate this ne...

Despite the lack of evidence to validate the effectiveness and safety of marijuana, it is approved to treat a variety of dermatologic conditions in the United States. Health Canada has listed psoriasis, dermatitis, and pruritus as potential therapeutic uses for cannabis. Furthermore, medical cannabis dispensaries have been making unsubstantiated claims about medical cannabis. It is important for dermatologists to know about the purported uses of medical cannabis to help patients navigate this ne...

Despite the lack of evidence to validate the effectiveness and safety of marijuana, it is approved to treat a variety of dermatologic conditions in the United States. Health Canada has listed psoriasis, dermatitis, and pruritus as potential therapeutic uses for cannabis. Furthermore, medical cannabis dispensaries have been making unsubstantiated claims about medical cannabis. It is important for dermatologists to know about the purported uses of medical cannabis to help patients navigate this ne...

One of the leading authorities on psoriasis in the world, Dr Kim Papp speaks with JCMS Editor-in-Chief Dr Kirk Barber about his outstanding report on vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. Dr Papp was the lead author on this multi-disciplinary effort. According to Dr Barber, the paper provides clinicians with a clear path to develop their own guidelines for use when assessing individual patients. Theme by Lee Rosevere

One of the leading authorities on psoriasis in the world, Dr Kim Papp speaks with JCMS Editor-in-Chief Dr Kirk Barber about his outstanding report on vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. Dr Papp was the lead author on this multi-disciplinary effort. According to Dr Barber, the paper provides clinicians with a clear path to develop their own guidelines for use when assessing individual patients. Theme by Lee Rosevere

One of the leading authorities on psoriasis in the world, Dr Kim Papp speaks with JCMS Editor-in-Chief Dr Kirk Barber about his outstanding report on vaccination guidelines for patients with immune-mediated disorders on immunosuppressive therapies. Dr Papp was the lead author on this multi-disciplinary effort. According to Dr Barber, the paper provides clinicians with a clear path to develop their own guidelines for use when assessing individual patients. Theme by Lee Rosevere

JCMS Editor-in-chief Dr Kirk Barber speaks with Dr Christian Murray, a co-author of a vast systematic review of the literature for patient indications for micrographic surgery. Dr Murray is an accredited Moh's surgeon, associate professor of medicine at Women's College at the University of Toronto and director of the ACMS-accredited Mohs Surgery Fellowship at the University of Toronto. This interview brings forward the difficulties in producing such a comprehensive study that is a product of a m...

JCMS Editor-in-chief Dr Kirk Barber speaks with Dr Christian Murray, a co-author of a vast systematic review of the literature for patient indications for micrographic surgery. Dr Murray is an accredited Moh's surgeon, associate professor of medicine at Women's College at the University of Toronto and director of the ACMS-accredited Mohs Surgery Fellowship at the University of Toronto. This interview brings forward the difficulties in producing such a comprehensive study that is a product of a m...

JCMS Editor-in-chief Dr Kirk Barber speaks with Dr Christian Murray, a co-author of a vast systematic review of the literature for patient indications for micrographic surgery. Dr Murray is an accredited Moh's surgeon, associate professor of medicine at Women's College at the University of Toronto and director of the ACMS-accredited Mohs Surgery Fellowship at the University of Toronto. This interview brings forward the difficulties in producing such a comprehensive study that is a product of a m...

Editor-in-Chief Dr Kirk Barber speaks with Dr Michele Ramien, a clinical associate professor of pediatric dermatology at University of Calgary and co-author of a study on the development of an eczema action plan (EAP) as an individualized tool to help caregivers and patients self-manage eczema. While novel illustrated EAPs have been developed and validated and this study supports those findings as it found caregivers and participants demonstrate the EAP is a useful and highly usable tool. Dr Bar...

Editor-in-Chief Dr Kirk Barber speaks with Dr Michele Ramien, a clinical associate professor of pediatric dermatology at University of Calgary and co-author of a study on the development of an eczema action plan (EAP) as an individualized tool to help caregivers and patients self-manage eczema. While novel illustrated EAPs have been developed and validated and this study supports those findings as it found caregivers and participants demonstrate the EAP is a useful and highly usable tool. Dr Bar...

Editor-in-Chief Dr Kirk Barber speaks with Dr Michele Ramien, a clinical associate professor of pediatric dermatology at University of Calgary and co-author of a study on the development of an eczema action plan (EAP) as an individualized tool to help caregivers and patients self-manage eczema. While novel illustrated EAPs have been developed and validated and this study supports those findings as it found caregivers and participants demonstrate the EAP is a useful and highly usable tool. Dr Bar...

Editor-in-chief of JCMS, Dr Kirk Barber speaks with Dr Afsaneh Alavi, a co-author of the study that aimed to systematically review the published evidence on the treatment of ulcerated hemangiomas, focusing on wound healing as the outcome of interest. Dr Alavi is a clinical dermatologist and Assistant Professor in the Faculty of Medicine (Division of Dermatology) at the University of Toronto.

Editor-in-chief of JCMS, Dr Kirk Barber speaks with Dr Afsaneh Alavi, a co-author of the study that aimed to systematically review the published evidence on the treatment of ulcerated hemangiomas, focusing on wound healing as the outcome of interest. Dr Alavi is a clinical dermatologist and Assistant Professor in the Faculty of Medicine (Division of Dermatology) at the University of Toronto.

Editor-in-chief of JCMS, Dr Kirk Barber speaks with Dr Afsaneh Alavi, a co-author of the study that aimed to systematically review the published evidence on the treatment of ulcerated hemangiomas, focusing on wound healing as the outcome of interest. Dr Alavi is a clinical dermatologist and Assistant Professor in the Faculty of Medicine (Division of Dermatology) at the University of Toronto.

Over the past decade, new technologies, devices, and methods have been developed to assist in the diagnosis of cutaneous melanocytic lesions. A study published in the November December 2018 issue of JCMS evaluates the performance of an augmented intelligence system in the assessment of atypical pigmented lesions. On this episode, Editor-In-Chief Dr Kirk Barber speaks with two of the paper's co-authors about the potential for this technology to augment and enhance clinical decision making for de...

Over the past decade, new technologies, devices, and methods have been developed to assist in the diagnosis of cutaneous melanocytic lesions. A study published in the November December 2018 issue of JCMS evaluates the performance of an augmented intelligence system in the assessment of atypical pigmented lesions. On this episode, Editor-In-Chief Dr Kirk Barber speaks with two of the paper's co-authors about the potential for this technology to augment and enhance clinical decision making for de...